The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety.

På svenska

Author

  • Sara Wiehager
  • Daniela I Beiderbeck
  • Susanne H M Gruber
  • Aram El-Khoury
  • Jackie Wamsteeker
  • Inga D Neumann
  • Åsa Petersén
  • Aleksander A Mathé

Summary, in English

The neurobiological bases of mood disorders remain elusive but both monoamines and neuropeptides may play important roles. The neuropeptide cocaine and amphetamine regulated transcript (CART) was shown to induce anxiety-like behavior in rodents, and mutations in the human CART gene are associated with depression and anxiety. We measured CART-like immunoreactivity (-LI) in genetic rat models of depression and anxiety, i.e. the Flinders Sensitive Line (FSL) and rats selected for High Anxiety-related Behavior (HAB) using a radioimmunoassay. CART-LI was significantly increased in the periaqueductal grey in FSL rats, whereas in the HAB strain it was increased in the hypothalamus, both compared with their respective controls. No line-dependent changes were found in the hippocampus, striatum or frontal cortex. Our results confirm human genetic studies indicating CART as a neurobiological correlate of depression and anxiety, and suggest that its differential regulation in specific brain regions may play a role for the behavioral phenotypes.

Publishing year

2009

Language

English

Pages

375-380

Publication/Series

Neurobiology of Disease

Volume

34

Document type

Journal article

Publisher

Elsevier

Topic

  • Neurosciences

Status

Published

Research group

  • Translational Neuroendocrinology

ISBN/ISSN/Other

  • ISSN: 0969-9961